Black Rock Inc. Supernus Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,392,636 shares of SUPN stock, worth $375 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,392,636
Previous 10,362,356
0.29%
Holding current value
$375 Million
Previous $353 Million
21.35%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SUPN
# of Institutions
282Shares Held
60.9MCall Options Held
27.7KPut Options Held
11.3K-
Vanguard Group Inc Valley Forge, PA6.13MShares$221 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$184 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$104 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$95.1 Million0.09% of portfolio
-
State Street Corp Boston, MA2.16MShares$77.9 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.93B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...